On Monday, December 9, 2019, ACCC hosted the IO Institute Telemedicine Roundtable in Dallas, Texas. As the U.S. continues to see increased demand for cancer care services, telemedicine and technology are becoming a vital component of delivering high-quality, value-based cancer care. Although innovative e-health platforms and virtual navigation services can improve patient access to care for patients who are appropriate for cancer immunotherapy treatment, implementation of, and reimbursement for, these services remains a complex endeavor. The IO Institute Telemedicine Roundtable aimed to address these issues and facilitate cross-field discussion on key priorities and next steps to help accelerate the advancement of telemedicine as part of immuno-oncology in the community setting.